Cargando…

Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells

BACKGROUND: Osteopontin is a secreted phosphoglycoprotein that is expressed by a number of normal cells as well as a variety of tumor cells. With respect to breast cancer, osteopontin has been implicated in regulating tumor cell proliferation and migration/metastasis and may serve as a prognostic in...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, S., Thompson, D. E., McConkey, J., Murray, P., Moorehead, R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901464/
https://www.ncbi.nlm.nih.gov/pubmed/27282619
http://dx.doi.org/10.1186/s12885-016-2396-9
_version_ 1782436809982083072
author Saleh, S.
Thompson, D. E.
McConkey, J.
Murray, P.
Moorehead, R. A.
author_facet Saleh, S.
Thompson, D. E.
McConkey, J.
Murray, P.
Moorehead, R. A.
author_sort Saleh, S.
collection PubMed
description BACKGROUND: Osteopontin is a secreted phosphoglycoprotein that is expressed by a number of normal cells as well as a variety of tumor cells. With respect to breast cancer, osteopontin has been implicated in regulating tumor cell proliferation and migration/metastasis and may serve as a prognostic indicator. However it remains unclear whether osteopontin has the same impact in all breast cancer subtypes and in particular, osteopontin’s effects in claudin-low breast cancer are poorly understood. METHODS: cDNA microarrays and qRT-PCR were used to evaluate osteopontin expression in mammary tumors from MTB-IGFIR transgenic mice and cell lines derived from these tumors. siRNA was then used to determine the impact of osteopontin knockdown on proliferation, apoptosis and migration in vitro in two murine claudin-low cell lines as well as identify the receptor mediating osteopontin’s physiologic effects. RESULTS: Osteopontin was expressed at high levels in mammary tumors derived from MTB-IGFIR transgenic mice compared to normal mammary tissue. Evaluation of cell lines derived from different mammary tumors revealed that mammary tumor cells with claudin-low characteristic expressed high levels of osteopontin whereas mammary tumor cells with mixed luminal and basal-like features expressed lower levels of osteopontin. Reduction of osteopontin levels using siRNA significantly reduced proliferation and migration while increasing apoptosis in the claudin-low cell lines. Osteopontin’s effect appear to be mediated through a receptor containing ITGAV and not through CD44. CONCLUSIONS: Our data suggests that mammary tumors with a mixed luminal/basal-like phenotype express high levels of osteopontin however this osteopontin appears to be largely produced by non-tumor cells in the tumor microenvironment. In contrast tumor cells with claudin-low characteristics express high levels of osteopontin and a reduction of osteopontin in these cells impaired proliferation, survival and migration.
format Online
Article
Text
id pubmed-4901464
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49014642016-06-11 Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells Saleh, S. Thompson, D. E. McConkey, J. Murray, P. Moorehead, R. A. BMC Cancer Research Article BACKGROUND: Osteopontin is a secreted phosphoglycoprotein that is expressed by a number of normal cells as well as a variety of tumor cells. With respect to breast cancer, osteopontin has been implicated in regulating tumor cell proliferation and migration/metastasis and may serve as a prognostic indicator. However it remains unclear whether osteopontin has the same impact in all breast cancer subtypes and in particular, osteopontin’s effects in claudin-low breast cancer are poorly understood. METHODS: cDNA microarrays and qRT-PCR were used to evaluate osteopontin expression in mammary tumors from MTB-IGFIR transgenic mice and cell lines derived from these tumors. siRNA was then used to determine the impact of osteopontin knockdown on proliferation, apoptosis and migration in vitro in two murine claudin-low cell lines as well as identify the receptor mediating osteopontin’s physiologic effects. RESULTS: Osteopontin was expressed at high levels in mammary tumors derived from MTB-IGFIR transgenic mice compared to normal mammary tissue. Evaluation of cell lines derived from different mammary tumors revealed that mammary tumor cells with claudin-low characteristic expressed high levels of osteopontin whereas mammary tumor cells with mixed luminal and basal-like features expressed lower levels of osteopontin. Reduction of osteopontin levels using siRNA significantly reduced proliferation and migration while increasing apoptosis in the claudin-low cell lines. Osteopontin’s effect appear to be mediated through a receptor containing ITGAV and not through CD44. CONCLUSIONS: Our data suggests that mammary tumors with a mixed luminal/basal-like phenotype express high levels of osteopontin however this osteopontin appears to be largely produced by non-tumor cells in the tumor microenvironment. In contrast tumor cells with claudin-low characteristics express high levels of osteopontin and a reduction of osteopontin in these cells impaired proliferation, survival and migration. BioMed Central 2016-06-10 /pmc/articles/PMC4901464/ /pubmed/27282619 http://dx.doi.org/10.1186/s12885-016-2396-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Saleh, S.
Thompson, D. E.
McConkey, J.
Murray, P.
Moorehead, R. A.
Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells
title Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells
title_full Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells
title_fullStr Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells
title_full_unstemmed Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells
title_short Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells
title_sort osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901464/
https://www.ncbi.nlm.nih.gov/pubmed/27282619
http://dx.doi.org/10.1186/s12885-016-2396-9
work_keys_str_mv AT salehs osteopontinregulatesproliferationapoptosisandmigrationofmurineclaudinlowmammarytumorcells
AT thompsonde osteopontinregulatesproliferationapoptosisandmigrationofmurineclaudinlowmammarytumorcells
AT mcconkeyj osteopontinregulatesproliferationapoptosisandmigrationofmurineclaudinlowmammarytumorcells
AT murrayp osteopontinregulatesproliferationapoptosisandmigrationofmurineclaudinlowmammarytumorcells
AT mooreheadra osteopontinregulatesproliferationapoptosisandmigrationofmurineclaudinlowmammarytumorcells